
Specification of Drug Substances and Products
Development and Validation of Analytical Methods
Resources
Description
Key Features
- Presents a critical assessment of the application of ICH guidelines on method validation and specification setting
- Written by subject-matter experts involved in the development and application of the guidelines
- Provides a comprehensive treatment of the analytical methodologies used in the analysis, control and specification of new drug substances and products
- Covers the latest statistical approaches (including analytical quality by design) in the development of specifications, method validation and shelf-life prediction
Readership
Scientists, managers, educators and consultants involved in the development and regulation of pharmaceutical products, especially those concerned with the Chemistry, Manufacturing and Controls (CMC) aspects of drug development. Includes analytical chemists, pre-formulation scientists, formulation scientists, process chemists, process engineers, and pharmaceutical microbiologists as well as those involved in regulatory affairs, quality control and quality assurance. Academic researchers involved in drug research and development, particularly those who collaborate with industry or serve as consultants; faculty and students pursuing post-graduate degrees in Pharmaceutical Analysis, Pharmaceutics or Pharmaceutical Chemistry and certificates in Regulatory Affairs or Quality Assurance
Table of Contents
PART 1 INTRODUCTION
1. Introduction
C. Riley, T. Rosanske and G. Reid
2. General Principles and Regulatory Considerations: Specifications and Shelf Life Setting
C. Riley and H. Yang
3. General Principles and Regulatory Considerations: Method Development and Validation
T. Rosanske
4. Application of Quality by Design (QbD) to the Development and Validation of Analytical Methods
D. Lloyd, J. Bergum and Q. Wang
5. Analytical Methods in the Clinical Phase of Development
J. Orr and G. Reid
6. Method Transfer
G. Reid
7. Process Analytical Technology
I. CleggPART 2 UNIVERSAL TESTS
8. Description and Identification
E. Parente
9. Assay and Impurities: Specifications
E. Kikovska-Stojanovska, C. Riley, A. Clarke, and R. Phelps
10. Assay and Impurities: Method Development and Life-Cycle Management
A. Clarke, C. Riley,and E. Kikovska-Stojanovska
11. Assay and Impurities: Method Validation
C. Riley, A. Clarke, E. Kikovska-Stojanovska
12. Mutagenic Impurities
S. Baerschi and B. Olsen
13. Residual Solvents
G. Reid
14. Inorganic Impurities (Elemental Impurities)
E. ParentePART 3 SPECIFIC TESTS: DRUG SUBSTANCES
15. Solid State Characterization
P. Tishmack, P. Smith, and P. Chen
16. Chiral Methods
B. He and D. Lloyd
17. Water Determination
D. Armstrong and M. TalebiPART 4 SPECIFIC TESTS DRUG PRODUCT
18. Drug Release: Oral Products
V. Gray and T. Rosanske
19. Topical Products
K. Thakker and R. Klein
20. Extractables and Leachables
K. Moyer and J. ScullPART 5 BIOTECHNOLOGY PRODUCTS
21..Regulatory Requirements for Setting Drug Substance and Drug Product Specifications
K. Amsberry and Y.H. Lai
22. Validation of Analytical Methods for Biotechnology Products
J. Dally and M, MonckPART 6 PHARMACOPEIAL METHODS
23. Pharmacopeial Methods and Test (Updated)
E. SheininPART 7 BIOLOGICAL FLUIDS
24. Biological Fluids
L. Yuan, L. Wang, L. Pan, Q. Ji
Product details
- No. of pages: 694
- Language: English
- Copyright: © Elsevier 2020
- Published: July 23, 2020
- Imprint: Elsevier
- Paperback ISBN: 9780081028247
- eBook ISBN: 9780081028254
About the Editors
Christopher M. Riley
Affiliations and Expertise
Thomas W. Rosanske
Affiliations and Expertise
George Reid
Affiliations and Expertise
Ratings and Reviews
There are currently no reviews for "Specification of Drug Substances and Products"